CIK 0001053369 · Non-accelerated filer<br>Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 223542636
- Phone
- 2017502646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- Open-market buys, last 90 days
- $34,590
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$34,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-03-06 | EPIC PHARMA LLC 10% owner | Sale | −773,050 | $0.90 | $692K | 68,960,049 |
| 2014-03-06 | EPIC INVESTMENTS, LLC 10% owner | Sale | −773,050 | $0.90 | $692K | 68,960,049 |
| 2014-02-25 | Dash Barry H Director | Grant or award | +220,106 | $0.09 | $20K | 1,013,331 |
| 2014-02-25 | TREPPEL JERRY Chairman of the Board | Grant or award | +330,159 | $0.09 | $30K | 2,760,006 |
| 2014-02-25 | NARINE JEENARINE Director | Grant or award | +220,106 | $0.09 | $20K | 6,177,728 |
| 2014-02-25 | Hakim Nasrat A President & CEO | Grant or award | +2,616,580 | $0.11 | $291K | 11,714,141 |
| 2014-02-25 | Ward Carter Julian CFO, Secretary, Treasurer | Grant or award | +330,159 | $0.09 | $30K | 875,582 |
| 2014-02-25 | NIGALAYE ASHOK G Chief Scientific Officer | Grant or award | +220,106 | $0.09 | $20K | 12,275,289 |
| 2014-02-25 | NIGALAYE ASHOK G Chief Scientific Officer | Conversion | +2,000,000 | $0.06 | $125K | 14,275,289 |
| 2014-02-25 | NIGALAYE ASHOK G Chief Scientific Officer | Conversion · Warrants | −2,000,000 | $0.06 | $125K | 1,333,333 |
| 2014-02-25 | WHITNELL JEFFREY A Director | Grant or award | +220,106 | $0.09 | $20K | 977,399 |
| 2014-02-07 | TREPPEL JERRY Chairman of the Board | Conversion | +4.24 | $141,442.72 | $600K | 4.24 |
| 2014-02-07 | TREPPEL JERRY Chairman of the Board | Conversion · Convertible Note | −600,000 | $141,442.72 | $84.9B | 0 |
| 2014-02-07 | Hakim Nasrat A President & CEO | Conversion | +100 | $100,000.00 | $10.0M | 100 |
| 2014-02-07 | Hakim Nasrat A President & CEO | Conversion · Convertible Note | −10,000,000 | $100,000.00 | $1.0e3B | 0 |
| 2014-01-13 | NARINE JEENARINE Director | Sale | −805,583 | $0.18 | $147K | 15,341,280 |
| 2014-01-13 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | −805,583 | $0.18 | $147K | 20,919,930 |
| 2014-01-13 | EPIC PHARMA LLC 10% owner | Sale | −805,583 | $0.18 | $147K | 69,733,099 |
| 2014-01-13 | EPIC INVESTMENTS, LLC 10% owner | Sale | −805,538 | $0.18 | $147K | 69,733,099 |
| 2013-12-05 | EPIC INVESTMENTS, LLC 10% owner | Sale | −275,000 | $0.13 | $35K | 71,004,867 |
Page 10 of 18 · 356 trades